Alector Inc.(ALEC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALEC Alector Inc.

未开盘 03-23 16:00:00 EDT

2.06

+0.01

+0.49%

盘后2.10

+0.04+1.94%

18:12 EDT

最高2.16	最低2.04	成交量40.87万
今开2.11	昨收2.05	日振幅6.10%
总市值2.27亿	流通市值1.91亿	总股本1.10亿
成交额85.31万	换手率0.44%	流通股本9,251万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALEC","market":"US","secType":"STK","nameCN":"Alector Inc.","latestPrice":2.06,"timestamp":1774296000000,"preClose":2.05,"halted":0,"volume":408741,"hourTrading":{"tag":"盘后","latestPrice":2.1,"preClose":2.06,"latestTime":"18:12 EDT","volume":12231,"amount":25215.82,"timestamp":1774303944133,"change":0.04,"changeRate":0.019417,"amplitude":0.019417},"delay":0,"changeRate":0.004878048780487918,"floatShares":92512099,"shares":110000000,"eps":-1.39,"marketStatus":"未开盘","change":0.01,"latestTime":"03-23 16:00:00 EDT","open":2.11,"high":2.16,"low":2.035,"amount":853073.9400569999,"amplitude":0.060976,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.39,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1549515600000,"exchange":"NASDAQ","adjPreClose":2.05,"preHourTrading":{"tag":"盘前","latestPrice":2.13,"preClose":2.05,"latestTime":"08:00 EDT","volume":200,"amount":426,"timestamp":1774267201007,"change":0.08,"changeRate":0.039024,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.1,"preClose":2.06,"latestTime":"18:12 EDT","volume":12231,"amount":25215.82,"timestamp":1774303944133,"change":0.04,"changeRate":0.019417,"amplitude":0.019417},"volumeRatio":0.544724,"impliedVol":0.706,"impliedVolPercentile":0.3865},"requestUrl":"/m/hq/s/ALEC","defaultTab":"news","newsList":[{"id":"2593469996","title":"2025生物制药5大失败临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2593469996","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593469996?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:10","pubTimestamp":1766455833,"startTime":"0","endTime":"0","summary":"Biospace近日总结了生物制药领域在2025年五项代价高昂的临床失败，并分析了其引发的连锁反应。Alector与GSK于2021年7月达成合作，GSK投入预付款7亿美元，并承诺最高15亿美元的里程碑付款，以合作研发两款神经领域药物。双方2021年协议中的第二款药物nivisnebart目前处于II期研发阶段，用于治疗早期阿尔茨海默病。▌诺和诺德GLP-1药物阿尔茨海默适应症临床试验失利在神经科学领域折戟的还有诺和诺德。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","SG9999001176.USD","BK4588","IE00BKVL7J92.USD","IE00BLSP4239.USD","LU0225284248.USD","SG9999013999.USD","BK4581","LU1894683348.USD","SG9999003800.SGD","LU0225771236.USD","LU1066053197.SGD","LU1093756325.SGD","GSK.UK","BK4532","LU1057294990.SGD","LU1883839398.USD","LU0170899867.USD","BK4533","LU0306806265.USD","SG9999001176.SGD","SG9999011175.SGD","LU0321505439.SGD","LU0058720904.USD","PFE","LU0122379950.USD","LU1023059063.AUD","IE00BBT3K403.USD","BK4139","BK4007","LU1066051498.USD","BK4213","IE0002270589.USD","IE000M9KFDE8.USD","IE00BZ1G4Q59.USD","BK4534","LU0234572021.USD","GSK","BK4550","SGXZ57979304.SGD","BK4585","LU1093756168.USD","LU0321505868.SGD","LU1829250122.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0154236417.USD","LU0306807586.USD","SG9999002224.SGD","BK4592","LU0289739699.SGD","LU1894683264.USD","BK4568","BMY","LU0868494617.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4599","IE00B19Z3581.USD","NVO","ALEC"],"gpt_icon":1},{"id":"1132954889","title":"新闻稿：Alector任命Neil Berkley为首席财务官和首席业务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1132954889","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132954889?lang=zh_cn&edition=full","pubTime":"2025-12-13 05:07","pubTimestamp":1765573622,"startTime":"0","endTime":"0","summary":"加利福尼亚州南旧金山，2025年12月12日-- Alector, Inc.是一家专注于开发对抗神经退行性疾病严重进展的临床阶段生物技术公司，今天宣布Neil Berkley已于2025年12月10日被任命为首席财务官。Berkley自2024年3月起担任Alector的首席业务官，自2025年6月起还兼任CBO和临时CFO。他将继续担任首席业务官。“Neil展示了卓越的领导能力、判断力、战略洞察力，以及对Alector使命的坚定承诺，” Alector首席执行官Arnon Rosenthal博士表示。“我很荣幸能以这种身份为Alector服务，”Berkley说道。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALEC","CFO"],"gpt_icon":0},{"id":"2584997315","title":"Alector, Inc.盘中异动 股价大涨5.65%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584997315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584997315?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:59","pubTimestamp":1763488799,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日01时59分，Alector, Inc.股票出现异动，股价急速拉升5.65%。截至发稿，该股报1.31美元/股，成交量68.0555万股，换手率0.62%，振幅7.26%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Olema Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Arvinas, Inc.涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1965.98%、1139.97%、436.10%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为106.34%、60.49%、59.39%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119015959a4aad60c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119015959a4aad60c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC","OLMA"],"gpt_icon":0},{"id":"2580438264","title":"Alector, Inc.盘中异动 快速跳水5.26%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580438264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580438264?lang=zh_cn&edition=full","pubTime":"2025-11-01 01:38","pubTimestamp":1761932293,"startTime":"0","endTime":"0","summary":"北京时间2025年11月01日01时38分，Alector, Inc.股票出现波动，股价急速下跌5.26%。截至发稿，该股报1.44美元/股，成交量216.63万股，换手率2.14%，振幅7.89%。Alector, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Rani Therapeutics Holdings, Inc.、Yd Bio Ltd C/Wts 28/08/2030、Cabaletta Bio, Inc.涨幅较大，Aditxt, Inc.、Intensity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1130.94%、363.96%、147.93%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Yd Bio Ltd C/Wts 28/08/2030、Rani Therapeutics Holdings, Inc.，振幅分别为155.88%、67.65%、59.66%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101013813974ca4e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101013813974ca4e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALEC","BK4139"],"gpt_icon":0},{"id":"2577339878","title":"葛兰素史克(GSK)与Alector(ALEC)合作药物latozinemab未能延缓痴呆症进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2577339878","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577339878?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:51","pubTimestamp":1761141072,"startTime":"0","endTime":"0","summary":"金吾财讯 | 葛兰素史克(GSK)声明其与美国生物科技公司Alector(ALEC)合作的试验性药物latozinemab未能延缓痴呆症进展，宣告又一款潜在痴呆症治疗药物研发失败。这款药物由Alector公司研发，针对的是一种名为“额颞叶痴呆”的痴呆症类型。葛兰素史克表示将终止该临床试验并分析结果。Alector周二表示，其试验性药物在一项晚期临床试验中未能减缓一种罕见痴呆症的进展，促使该公司终止了这项研究，并裁减了近一半的员工。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"293686","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSK","GSK.UK","ALEC","BK4532","BK4588","BK4007","BK4139","BK4585"],"gpt_icon":0},{"id":"2577237319","title":"Alector, Inc.股价重挫51.40% 市值跌8116.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577237319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577237319?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:31","pubTimestamp":1761139917,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日21时31分，Alector, Inc.股票出现异动，股价大幅下挫51.40%。截至发稿，该股报1.56美元/股，成交量808.111万股，换手率7.98%，振幅1.87%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Rani Therapeutics Holdings, Inc.、Ethzilla Corporation C/Wts 06/11/2025、Cytomed Therapeutics Limited涨幅较大，Rani Therapeutics Holdings, Inc.、Minerva Neurosciences, Inc、Arcturus Therapeutics Holdings Inc.较为活跃，换手率分别为28.63%、13.23%、10.23%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Rani Therapeutics Holdings, Inc.、Minerva Neurosciences, Inc，振幅分别为18.93%、10.53%、8.27%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022213157a6c82166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022213157a6c82166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ALEC","BK4139"],"gpt_icon":1},{"id":"1153688071","title":"Alector盘前暴跌，其阿尔茨海默症药物未能延缓病情进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1153688071","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153688071?lang=zh_cn&edition=full","pubTime":"2025-10-22 16:15","pubTimestamp":1761120910,"startTime":"0","endTime":"0","summary":"该公司将停止此项目的继续研究，并裁员49%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALEC"],"gpt_icon":0},{"id":"1193175810","title":"Alector发布Grn突变所致额叶颞叶痴呆患者Latozinemab三期临床试验的初步结果并提供业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1193175810","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193175810?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:05","pubTimestamp":1761077110,"startTime":"0","endTime":"0","summary":"Alector发布Grn突变所致额叶颞叶痴呆患者Latozinemab三期临床试验的初步结果并提供业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALEC","BK4139"],"gpt_icon":0},{"id":"2575214751","title":"Alector, Inc.盘中异动 股价大跌5.10%报2.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575214751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575214751?lang=zh_cn&edition=full","pubTime":"2025-10-14 22:31","pubTimestamp":1760452293,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日22时31分，Alector, Inc.股票出现异动，股价大幅跳水5.10%。截至发稿，该股报2.89美元/股，成交量27.8292万股，换手率0.27%，振幅3.62%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2560.20%、30.46%、22.83%，振幅较大的相关个股有Pmgc Holdings Inc.、Genprex, Inc.、Bio Green Med Solution, Inc.，振幅分别为49.13%、25.72%、21.16%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014223134a6b92a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014223134a6b92a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALEC","BK4139"],"gpt_icon":0},{"id":"2568323253","title":"Alector, Inc.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568323253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568323253?lang=zh_cn&edition=full","pubTime":"2025-09-19 01:22","pubTimestamp":1758216162,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日01时22分，Alector, Inc.股票出现波动，股价快速上涨5.08%。截至发稿，该股报3.10美元/股，成交量30.2926万股，换手率0.30%，振幅5.25%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Adaptimmune Therapeutics Plc、89Bio, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.、Biocardia, Inc.较为活跃，换手率分别为3263.55%、1286.89%、326.89%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为119.06%、55.32%、53.46%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919012242a4ce1c95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919012242a4ce1c95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC"],"gpt_icon":0},{"id":"2518242162","title":"Alector, Inc.盘中异动 大幅下挫5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518242162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518242162?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:37","pubTimestamp":1741613873,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时37分，Alector, Inc.股票出现异动，股价快速下挫5.55%。截至发稿，该股报1.36美元/股，成交量3.5007万股，换手率0.04%，振幅1.51%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为470.38%、72.19%、52.12%，振幅较大的相关个股有Seer, Inc.、Scisparc Ltd.、Trevi Therapeutics, Inc.，振幅分别为98.72%、34.57%、25.35%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213753abf2fec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213753abf2fec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC"],"gpt_icon":0},{"id":"2517545585","title":"大摩：假定Alector(ALEC.US)减持评级, 目标价由3.00美元调整至1.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517545585","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517545585?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:13","pubTimestamp":1741367594,"startTime":"0","endTime":"0","summary":"大摩：假定Alector(ALEC.US)减持评级, 目标价由3.00美元调整至1.50美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08011348604865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALEC"],"gpt_icon":0},{"id":"2517792344","title":"Alector, Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517792344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517792344?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:15","pubTimestamp":1741202121,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时15分，Alector, Inc.股票出现异动，股价快速上涨5.15%。截至发稿，该股报1.53美元/股，成交量39.147万股，换手率0.40%，振幅8.21%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为2.21%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为958.08%、313.25%、306.06%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.，振幅分别为82.59%、54.27%、50.73%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031521abea0108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031521abea0108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC"],"gpt_icon":0},{"id":"2516672782","title":"Alector, Inc.盘中异动 早盘急速跳水5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516672782?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098916,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分，Alector, Inc.股票出现异动，股价大幅跳水5.67%。截至发稿，该股报1.33美元/股，成交量9.6358万股，换手率0.10%，振幅7.50%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1076.47%、1070.68%、423.99%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、12.01%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516963945bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516963945bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALEC","BK4139"],"gpt_icon":0},{"id":"2516632055","title":"Alector, Inc.盘中异动 股价大跌5.18%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516632055?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:58","pubTimestamp":1741013930,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时58分，Alector, Inc.股票出现异动，股价快速下挫5.18%。截至发稿，该股报1.56美元/股，成交量54.2835万股，换手率0.55%，振幅5.18%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为910.80%、118.62%、94.84%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225850a25d4840&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225850a25d4840&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALEC","BK4139"],"gpt_icon":0},{"id":"2516548227","title":"Alector, Inc.2024财年实现净利润-1.19亿美元，同比增加8.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516548227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516548227?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931282,"startTime":"0","endTime":"0","summary":"3月3日，Alector, Inc.公布财报，公告显示公司2024财年净利润为-1.19亿美元，同比增加8.46%；其中营业收入为1.01亿美元，同比增加4.06%，每股基本收益为-1.23美元。从资产负债表来看，Alector, Inc.总负债3.42亿美元，其中短期债务8.75百万美元，资产负债比为1.37，流动比率为3.40。机构评级：截至2025年3月3日，当前有7家机构对Alector, Inc.目标价做出预测，其中目标均价为4.44美元，其中最低目标价为1.00美元，最高目标价为8.56美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000208abe4aced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000208abe4aced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALEC"],"gpt_icon":0},{"id":"2514201963","title":"Alector, Inc.盘中异动 早盘股价大跌5.42%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514201963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514201963?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753258,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Alector, Inc.股票出现波动，股价快速下跌5.42%。截至发稿，该股报1.57美元/股，成交量4.8672万股，换手率0.05%，振幅6.80%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为487.98%、246.21%、107.90%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.、Anaptysbio, Inc.，振幅分别为31.14%、24.06%、16.04%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822341996341a0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822341996341a0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC"],"gpt_icon":0},{"id":"1141362595","title":"Alector 2024年第四季度GAAP每股收益为$(0.02)，同比增长$(0.49)，销售额为$5424.0万，超出预期$1662.1万","url":"https://stock-news.laohu8.com/highlight/detail?id=1141362595","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141362595?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:34","pubTimestamp":1740605684,"startTime":"0","endTime":"0","summary":"Alector 报告季度每股亏损$。这一数字相比去年同期每股亏损$增长了95.92%。公司报告季度销售额为$5424.0万，超出分析师一致预期的$1662.1万，超出预期226.33%。以上内容来自Benzinga Earnings专栏，原文如下：Alector  reported quarterly losses of $ per share. This is a 95.92 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $54.240 million which beat the analyst consensus estimate of $16.621 million by 226.33 percent.  This is a 257.08 percent increase over sales of $15.190 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alector 2024年第四季度GAAP每股收益为$(0.02)，同比增长$(0.49)，销售额为$5424.0万，超出预期$1662.1万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALEC"],"gpt_icon":0},{"id":"2514869835","title":"Alector, Inc.盘中异动 快速下跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514869835?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:38","pubTimestamp":1740595114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时38分，Alector, Inc.股票出现异动，股价大幅跳水5.37%。截至发稿，该股报1.68美元/股，成交量23.7043万股，换手率0.24%，振幅6.78%。Alector, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Enveric Biosciences, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6466.76%、278.21%、248.62%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为194.07%、64.29%、51.35%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702383496317cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702383496317cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC"],"gpt_icon":0},{"id":"2513778027","title":"Alector, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778027?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:31","pubTimestamp":1740411080,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时31分，Alector, Inc.股票出现波动，股价急速下跌5.08%。截至发稿，该股报1.78美元/股，成交量3.5794万股，换手率0.04%，振幅6.58%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为205.11%、86.17%、27.91%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233120abdb1c19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233120abdb1c19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alector.com;investors.alector.com","stockEarnings":[{"period":"1week","weight":-0.0679},{"period":"1month","weight":0.0352},{"period":"3month","weight":0.461},{"period":"6month","weight":-0.3481},{"period":"1year","weight":0.5259},{"period":"ytd","weight":0.3205}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alector, Inc.最初于2013年5月在特拉华州成立为有限责任公司,是临床阶段的生物制药公司。开创性的免疫神经学，是一种治疗神经变性的新型治疗方法。免疫神经学将免疫功能障碍作为多种病理学的根本原因，这些病理学是退行性脑病的驱动因素。他们正在开发旨在通过恢复大脑的健康免疫功能来同时抵消这些病症的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.042134},{"month":2,"riseRate":0.428571,"avgChangeRate":0.067604},{"month":3,"riseRate":0.125,"avgChangeRate":-0.121578},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.055292},{"month":5,"riseRate":0.428571,"avgChangeRate":0.030589},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.004123},{"month":7,"riseRate":0.857143,"avgChangeRate":0.062831},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.001024},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.031305},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.094127},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.021962},{"month":12,"riseRate":0.571429,"avgChangeRate":0.077226}],"exchange":"NASDAQ","name":"Alector Inc.","nameEN":"Alector Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alector Inc.(ALEC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alector Inc.(ALEC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alector Inc.,ALEC,Alector Inc.股票,Alector Inc.股票老虎,Alector Inc.股票老虎国际,Alector Inc.行情,Alector Inc.股票行情,Alector Inc.股价,Alector Inc.股市,Alector Inc.股票价格,Alector Inc.股票交易,Alector Inc.股票购买,Alector Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alector Inc.(ALEC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alector Inc.(ALEC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}